MGMT and neoplasm: While MGMT promoter methylation predicts a more favorable treatment response, in some malignant glioma patients treated with radiotherapy in combination with temozolomide it is shown to be associated with pseudoprogression, a pathological feature that can imitate true tumor progression on followup diagnostic imaging.